Glycom A/s

Neuroscios Gmbh

Johan Olsson

Markus Hederos

Lars Kröger

Andreas Schroven

Christoph Röhrig

Julien Boutet

Piroska Kovács-Pénzes

Ferenc Horváth

Ioannis Vrasidas

Ignacio Pérez Figueroa

Károly Ágoston

István Bajza

Gyula Dékany

Istvan Bajza

Marie Bøjstrup

Kristin Hammer

Peter Åsberg

Ignacio Figueroa Pérez

Mette Fanefjord

Martin Henriksson

Gyula DÉKANY

The present invention relates to novel chemical compounds formula (I) (C)&#x2014;B-(A)-B&#x2014;(C)(I) wherein m is 0 or 1, and n is independently 0, 1, 2 or 3, A, each B and each C are independently selected from phenylene and five- and six-membered heteroaromatic rings, and for a terminal ring B or C also from bicyclic heteroaromatic fused rings having seven to ten ring members, wherein the bond between at least two of the rings A to C may be replaced by a carbonyl group (&#x2014;CO&#x2014;), wherein at least two of the rings A to C are substituted with one or two groups R, and wherein each ring A to C further optionally is substituted with one or two groups R. The compounds are useful in therapy, especially therapy of a mammal suffering from a disease involving misfolded or aggregated forms of proteins.

Substituted aromatic oligomers

The present invention relates to an improved synthesis of a trisaccharide of the formula (1), novel intermediates used in the synthesis and the preparation of the intermediates. 

Method for the synthesis of a trisaccharide

The present invention relates to an improved synthesis of a trisaccharide of the formula, novel intermediates used in the synthesis and the preparation of the intermediates. 

Growing community of inventors

Stockholm, Sweden

Johan Olsson